These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7809150)

  • 1. Enzyme replacement in a canine model of Hurler syndrome.
    Shull RM; Kakkis ED; McEntee MF; Kania SA; Jonas AJ; Neufeld EF
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12937-41. PubMed ID: 7809150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.
    Kakkis ED; McEntee MF; Schmidtchen A; Neufeld EF; Ward DA; Gompf RE; Kania S; Bedolla C; Chien SL; Shull RM
    Biochem Mol Med; 1996 Aug; 58(2):156-67. PubMed ID: 8812735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy in feline mucopolysaccharidosis I.
    Kakkis ED; Schuchman E; He X; Wan Q; Kania S; Wiemelt S; Hasson CW; O'Malley T; Weil MA; Aguirre GA; Brown DE; Haskins ME
    Mol Genet Metab; 2001 Mar; 72(3):199-208. PubMed ID: 11243725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.
    Dierenfeld AD; McEntee MF; Vogler CA; Vite CH; Chen AH; Passage M; Le S; Shah S; Jens JK; Snella EM; Kline KL; Parkes JD; Ware WA; Moran LE; Fales-Williams AJ; Wengert JA; Whitley RD; Betts DM; Boal AM; Riedesel EA; Gross W; Ellinwood NM; Dickson PI
    Sci Transl Med; 2010 Dec; 2(60):60ra89. PubMed ID: 21123810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.
    Kakkis E; McEntee M; Vogler C; Le S; Levy B; Belichenko P; Mobley W; Dickson P; Hanson S; Passage M
    Mol Genet Metab; 2004; 83(1-2):163-74. PubMed ID: 15464431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
    Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
    Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.
    Shull RM; Hastings NE; Selcer RR; Jones JB; Smith JR; Cullen WC; Constantopoulos G
    J Clin Invest; 1987 Feb; 79(2):435-43. PubMed ID: 3100576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
    Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
    Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase.
    Shull RM; Lu X; McEntee MF; Bright RM; Pepper KA; Kohn DB
    Hum Gene Ther; 1996 Aug; 7(13):1595-603. PubMed ID: 8864760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I.
    Kakkis E; Lester T; Yang R; Tanaka C; Anand V; Lemontt J; Peinovich M; Passage M
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):829-34. PubMed ID: 14715900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of recombinant gene product to canine brain with the use of microencapsulation.
    Barsoum SC; Milgram W; Mackay W; Coblentz C; Delaney KH; Kwiecien JM; Kruth SA; Chang PL
    J Lab Clin Med; 2003 Dec; 142(6):399-413. PubMed ID: 14713892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations.
    Vite CH; Wang P; Patel RT; Walton RM; Walkley SU; Sellers RS; Ellinwood NM; Cheng AS; White JT; O'Neill CA; Haskins M
    Mol Genet Metab; 2011 Jul; 103(3):268-74. PubMed ID: 21482164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.
    Dickson PI; Ellinwood NM; Brown JR; Witt RG; Le SQ; Passage MB; Vera MU; Crawford BE
    Mol Genet Metab; 2012 May; 106(1):68-72. PubMed ID: 22402327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid.
    Dickson P; McEntee M; Vogler C; Le S; Levy B; Peinovich M; Hanson S; Passage M; Kakkis E
    Mol Genet Metab; 2007 May; 91(1):61-8. PubMed ID: 17321776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells.
    Kakkis ED; Matynia A; Jonas AJ; Neufeld EF
    Protein Expr Purif; 1994 Jun; 5(3):225-32. PubMed ID: 7950365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment.
    Gabrielli O; Clarke LA; Ficcadenti A; Santoro L; Zampini L; Volpi N; Coppa GV
    BMC Med Genet; 2016 Mar; 17():19. PubMed ID: 26965916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Feb; 99(2):475-84. PubMed ID: 17680664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.